Physician profile
Caroline D Stelle
NPI 1912599184
$473.36
in general payments reported to CMS, 2019-2025
12 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.76 · 2022: $103 · 2023: $79.74 · 2024: $117 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $112.45 | 2022-2025 | In.Pact Admiral, Spiderfx |
| Boston Scientific Corporation | $95.25 | 2022-2025 | Varithena Administration Pack, Enroute Transcarotid Stent |
| Smith+Nephew, INC. | $55.84 | 2024-2025 | Collagenase Santyl |
| Shape Memory Medical INC. | $41.11 | 2025 | Impede Embolization Plug |
| Tactile Systems Technology INC | $39.59 | 2021-2022 | |
| Inari Medical, INC. | $24.15 | 2022 | |
| Silk Road Medical, INC. | $23.82 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Stryker Corporation | $18.85 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Surmodics, INC. | $17.08 | 2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Ethicon US, LLC | $17.01 | 2025 | Surgicel Nu-Knit, Vistaseal, Ethicon |
| Janssen Pharmaceuticals, INC | $15.78 | 2023 | Xarelto |
| Lemaitre Vascular, INC. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Stelle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.